Calumet (CLMT) Q4 2025 earnings summary

Executive summary

• Achieved all major 2025 strategic objectives, including durable free cash flow in specialties, financial resilience at Montana Renewables, DOE loan closure, and significant deleveraging, with $222 million in recourse debt reduction.

• Adjusted EBITDA with Tax Attributes rose to $293.3 million, up nearly 30% year-over-year, reflecting strong operational improvements and cost reductions.

• Fiscal year 2025 net loss was $33.8 million, a significant improvement from a $222.0 million net loss in 2024.

• Record production achieved in both Specialty Products & Solutions and Montana Renewables segments.

• Completed the divestiture of Royal Purple Industrial and secured a DOE loan, reducing annual debt service by ~$80 million.

Financial highlights

• Adjusted EBITDA with Tax Attributes reached $69.3 million for Q4 and $293.3 million for FY2025, up from $229.3 million in FY2024.

• Net recourse leverage improved from 8.2x to as low as 3.9x by year-end 2025; restricted debt reduced by over $220 million.

• Sales for 2025 were $4,137.1 million, slightly down from $4,189.4 million in 2024.

• Operating income improved to $108.7 million from $8.1 million in 2024.

• Net cash provided by operating activities was $108.9 million, reversing a negative $46.4 million in 2024.

Outlook and guidance

• Montana Renewables MaxSAF 150 expansion remains on track for completion in Q2 2026, with ~100 million gallons of SAF contracted at a $1–$2/gal premium to renewable diesel.

• 2026 CapEx forecasted at $115–$145 million, higher due to heavy turnaround year.

• Expect production to increase year-over-year despite scheduled maintenance.

• Anticipated regulatory support, including finalized RVO and 45Z, expected to improve industry margins in 2026.

• Management expects continued growth and long-term value creation, citing a strengthened balance sheet and durable business model.